Related Experiment Videos
Cancer prevention: a worldwide overview
1Department of Public Health Science, University of Toronto, Canada.
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effects of pituitary pars intermedia dysfunction and Prascend (pergolide tablets) treatment on endocrine and immune function in horses.
Domestic animal endocrinology·2020
The role of screening mammography in the era of modern breast cancer treatment.
Climacteric : the journal of the International Menopause Society·2018
The OncoSim model: development and use for better decision-making in Canadian cancer control.
Current oncology (Toronto, Ont.)·2017
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Becotatug Vedotin for Recurrent/Metastatic Nasopharyngeal Carcinoma (Magic-M001): A Multicenter, Randomized Trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
GLP-1 receptor agonist use and cancer risk in obese nondiabetic adults.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Individual-level HPV vaccination verification in Botswana: lessons learned from implementation of the HOPE II trial.
Frontiers in public health·2026